Search results
Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View
Zacks via Yahoo Finance· 11 months agoAlkermes ALKS received a final award in its arbitration proceedings with Janssen Pharmaceuticals, a...
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Janssen Touts Encouraging Data From Two Ulcerative Colitis Treatments
Benzinga via Yahoo Finance· 2 years agoJanssen Pharmaceutical, a unit of Johnson & Johnson (NYSE: JNJ), announced data from an ongoing...
FDA Approves Johnson & Johnson's Ready To Use Cell Therapy For Multiple Myeloma
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Janssen Pharmaceutical's, a unit of Johnson & Johnson (NYSE: JNJ), Tecvayli...
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
Benzinga via Yahoo Finance· 2 years agoJanssen Biotech Inc, a Johnson & Johnson (NYSE: JNJ) unit, received European conditional approval...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 9 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Biotech Stock Roundup: BMY's Study Update, INCY's Drug Label Expansion, MRNA News
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Motley Fool· 8 months agoOn average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. Viatris (NASDAQ: VTRS), GSK (NYSE: GSK), and...
Here's How Much You'd Have If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago
Zacks via Yahoo Finance· 4 months agoFor most investors, how much a stock's price changes over time is important. Not only can it impact...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...